Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rimoldi

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|March 10, 2001
Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanomaM Berset, J P Cerottini, D Guggisberg, et al.
Medicina|November 28, 2001
[Ovarian abscess due to Actinomyces sp. in absence of an intrauterine contraceptive device]S C Burlando, L A Paz, L G De Feo, et al.
The Journal of Biological Chemistry|May 24, 1996
HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44I F Luescher, P Romero, D Kuznetsov, et al.
Cancer Research|November 1, 1991
Development of resistance to the growth inhibitory effects of transforming growth factor beta 1 during the spontaneous transformation of rat liver epithelial cellsA C Huggett, P A Ellis, C P Ford, et al.
International Journal of Cancer|October 16, 1999
Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA librariesA Serrano, B Lethé, J M Delroisse, et al.
Anticancer Research|May 1, 1993
Expression of IL-2 receptors in human melanoma cellsD Rimoldi, S Salvi, F Hartmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell lineG A Waanders, D Rimoldi, D Liénard, et al.
International Immunopharmacology|July 20, 2001
Ex vivo analysis of tumor antigen specific CD8+ T cell responses using MHC/peptide tetramers in cancer patientsM J Pittet, D E Speiser, D Valmori, et al.
Cancer Research|May 8, 1999
An antigen-targeted approach to adoptive transfer therapy of cancerD Valmori, M J Pittet, D Rimoldi, et al.
Cancer Research|February 24, 2001
Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanomaD Valmori, V Dutoit, V Rubio-Godoy, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|March 10, 2001
Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanomaM Berset, J P Cerottini, D Guggisberg, et al.
Medicina|November 28, 2001
[Ovarian abscess due to Actinomyces sp. in absence of an intrauterine contraceptive device]S C Burlando, L A Paz, L G De Feo, et al.
The Journal of Biological Chemistry|May 24, 1996
HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44I F Luescher, P Romero, D Kuznetsov, et al.
Cancer Research|November 1, 1991
Development of resistance to the growth inhibitory effects of transforming growth factor beta 1 during the spontaneous transformation of rat liver epithelial cellsA C Huggett, P A Ellis, C P Ford, et al.
International Journal of Cancer|October 16, 1999
Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA librariesA Serrano, B Lethé, J M Delroisse, et al.
Anticancer Research|May 1, 1993
Expression of IL-2 receptors in human melanoma cellsD Rimoldi, S Salvi, F Hartmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell lineG A Waanders, D Rimoldi, D Liénard, et al.
International Immunopharmacology|July 20, 2001
Ex vivo analysis of tumor antigen specific CD8+ T cell responses using MHC/peptide tetramers in cancer patientsM J Pittet, D E Speiser, D Valmori, et al.
Cancer Research|May 8, 1999
An antigen-targeted approach to adoptive transfer therapy of cancerD Valmori, M J Pittet, D Rimoldi, et al.
Cancer Research|February 24, 2001
Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanomaD Valmori, V Dutoit, V Rubio-Godoy, et al.
Pageof 7